NYSE · PG
The Procter & Gamble Company
$160.59+$2.33 (+1.47%)
The Procter & Gamble Company’s quoted price sits in the upper half of its reported 52-week range, 3.98% below the high.
Loading market information…
NYSE · KVUE · USD
Stock price, dividends, earnings
Quote as of Oct 29, 2026, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Kenvue Inc.’s quoted price sits in the upper half of its reported 52-week range, 2.83% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Kenvue Inc.’s forward annual dividend is $2.52 per share, paid monthly. The forward yield is 12.88% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
Kenvue Inc.’s next earnings report is currently expected on Oct 30, 2026, with estimated earnings per share of $0.29. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow Kenvue Inc.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Kenvue Inc. functions as a global leader in the consumer health sector. The company structures its operations across three primary divisions: Self Care, Skin Health and Beauty, and Essential Health. Within the Self Care unit, it offers a diverse range of products for common conditions like coughs, colds, and allergies, in addition to pain relief, digestive health, and smoking cessation aids, featuring prominent brands such as Tylenol, Nicorette, and Zyrtec. The Skin Health and Beauty segment delivers various solutions for facial, body, hair, and sun protection, recognized under popular labels including Neutrogena, Aveeno, and OGX. Moreover, the Essential Health category provides oral hygiene, infant care, feminine wellness, and wound treatment products, marketed through esteemed brands like Listerine, Johnson's, Band-Aid, and Stayfree. Established in 2022, Kenvue Inc. maintains its corporate headquarters in Skillman, New Jersey, and operates as a subsidiary of Johnson & Johnson.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 01:41 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
| May 8, 2025 |
| $0.24+5.49% vs estimate |
| $3.74B+1.73% vs estimate |
| Q4 2024 | Feb 6, 2025 | $0.260.0% vs estimate | $3.66B-2.61% vs estimate |
|---|
| Q3 2024 | Nov 7, 2024 | $0.28+2.83% vs estimate | $3.90B-0.53% vs estimate |
|---|
THE ANALYST VIEW
14 ratings in the current snapshot. Strong buy and strong sell are grouped with buy and sell.
Percentages compare targets with the quoted price when currencies match. Targets are analyst estimates, not guaranteed outcomes.
Consensus coverage: 2 contributors · Median target $19.50.
Average targets in published notes for each window. These figures use a different sample from the consensus above.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$160.59+$2.33 (+1.47%)
The Procter & Gamble Company’s quoted price sits in the upper half of its reported 52-week range, 3.98% below the high.
€424.50+€0.85 (+0.2%)
L'Oréal S.A.’s quoted price sits in the upper half of its reported 52-week range, 4.04% below the high.
$64.18+$0.24 (+0.38%)
Unilever PLC’s quoted price sits in the lower half of its reported 52-week range, 14.4% below the high.
$93.16+$1.47 (+1.6%)
Colgate-Palmolive Company’s quoted price sits in the upper half of its reported 52-week range, 6.21% below the high.
£52.82+£0.58 (+1.11%)
Reckitt Benckiser Group plc’s quoted price sits in the upper half of its reported 52-week range, 19.02% below the high.
$108.81-$0.50 (-0.46%)
The Estée Lauder Companies Inc.’s quoted price sits in the upper half of its reported 52-week range, 10.55% below the high.
$8.57-$1.43 (-14.3%)
Haleon plc’s quoted price sits in the lower half of its reported 52-week range, 24.02% below the high.
$106.00+$1.25 (+1.19%)
Church & Dwight Co., Inc.’s quoted price sits in the upper half of its reported 52-week range, 2.69% below the high.
